HIGHLIGHTS
- who: Abbas Norouzi Javidan et al. from the University of Medical SciencesMedical Sciences, Tehran, Iran have published the Article: Safety and efficacy of PDpoetin for management of anemia in patients with end stage renal disease on mainte- nance hemodialysis: results from a phase IV clinical trial, in the Journal: (JOURNAL)
- what: The aim of this study is to scrutinize effectiveness and possible side effects of PDpoetin in a post marketing surveillance study. Hemoglobin and hematocrit changes the study showed about 1.7u00b10.6 g/dL of hemoglobin increase in patients after 4 months of treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.